Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis

Advances in Experimental Medicine and Biology

Volumn 451, Issue , 1998, Pages 43-49

  Gunthert U ^a   Schwarzler C ^a   Wittig, B ^b   Laman, J ^c   Ruiz, P ^d   Stauder, R ^e   Bloem, A ^f   Smadja Joffe, F ^g   Zoller M ^b   Rolink, A ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c TNO   (Netherlands)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON RECEPTOR; HERMES ANTIGEN; INTERFERON RECEPTOR; ISOPROTEIN; CD4 ANTIGEN; CD44V ANTIGEN; CD8 ANTIGEN;

ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; C57BL MOUSE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COLITIS; EXON; GENE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENETICS; HEMATOPOIESIS; IMMUNOLOGY; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PHYSIOLOGY; TH1 CELL; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD DISEASE; CELL ADHESION; GENE DELETION; IMMUNE RESPONSE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL; THYMOCYTE; THYMUS; TRANSGENIC MOUSE; TUMOR GROWTH;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; CYTOKINES; EXONS; GENES, MHC CLASS II; HEMATOPOIESIS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PROTEIN ISOFORMS; RECEPTORS, INTERFERON; RECOMBINATION, GENETIC; TH1 CELLS; VARIATION (GENETICS);

EID: 0032249736     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5357-1_7     Document Type: Article

References (19)

1. Ruiz, P., Günthert, U., 1996: The cellular basis of metastasis. World J. Urol. 14, 141-150.
2. Günthert, U., 1996: CD44 in malignant disorders. Current Topics Microbiol. Immunol. 213-1: 271-285.
3. Editors U. Günthert, W. Birchmeier and P.M. Schlag of Vol. 213 I, II, III: Attempts to understand metastasis formation. Springer, Heidelberg.
4. Stauder, R., Günthert, U., 1995: CD44 isoforms - impact on lymphocyte activation and differentiation. The Immunologist 3, 78-83.
5. Ruiz, P., Schwärzler, C., Günthert, U., 1995: CD44 isoforms during differentiation and development. BioEssays 17, 17-24.
6. Günthert, U., Stauder, R., Mayer, B., Terpe, H.-J., Finke, L., Friedrichs, K., 1995: Are CD44 variant isoforms involved in human tumour progression? Cancer Surveys 24 , 19-42 .
7. Rosenberg, W.M.C., Prince, C., Kaklamanis, L., Fox, S.B., Jackson, D.G., Simmons, D.L., Chapman, R.W., Trowell, J.M., Jewell, D.P., Bell, J.I., 1995: Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345, 1205-1209.
8. Neurath, M.F., Fuss, I., Kelsall, B.L., Stüber, E.R., Strober, W., 1995: Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1281-1290.
9. Wittig, B., Seiter, S., Föger, N., Schwärzler, C., Günthert, U., Zöller, M., 1997: Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol. Lett. 57: 217-223.
10. Powrie, F., 1995: T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3, 171-174.
11. Gerritse, K., Laman, J.D., Noelle, R.J., Aniffo, A., Ledbetter, J.A., Boersma, W.J.A., Claassen, E., 1996: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499-2504.
12. Mikecz, K., Brennan, F.R., Kim, J.H., Glant, T.T., 1995: Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nature Med. 1, 558-563.
13. Dzierzak, E., Medvinsky, A., 1995: Mouse embryonic hematopoiesis. TIG 11, 359-366.
14. Zuniga-Pflücker, J.C., Lenardo, M., 1996: Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8, 215-224.
15. Wu, L., Kincade, P.W., Shortman K., 1993: The CD44 expressed on the earliest intrathymic precursors population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol. Letters 38, 69-75.
16. Rolink, A., Andersson, J., Ghia, P., Grawunder, U., Haasner, D., Karasuyama, H., ten Boekel, E., Winkler, T.H., Melchers, F., 1995: B-cell development in mouse and men. Immunologist 3/4, 125-128.
17. Stauder, R., Eisterer, A., Thaler, J., Günthert, U., 1995: CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 85, 2885-2899.
18. Stauder, R., Van Driel, M., Schwärzler, C., Thaler, J., Lokhorst, H.M., Kreuser, E.D., Bloem, A.C., Günthert, U., Eisterer, W., 1996: Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 88: 3101-3108.
19. Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W, Bujard, H., 1995: Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.